Fundraising FoxPrometheus Therapeutics
Miramar, US · Delaware corporation
Find your way into Prometheus Therapeutics
Sign up to see every warm intro you have to Prometheus Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Prometheus Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BN
Bernie NavarroExecutive
BL
Baruch LieberNamed on SEC filing
AW
Ajay WakhlooNamed on SEC filing
ML
Marc LitzenbergNamed on SEC filing
Board
AH
Alexander HastingsBoard director
JM
John McEleneyBoard director
Reported raises · per SEC filings
Form D private placements$11.6M disclosed across 4 rounds · 2020–2025
▶$2.7MraisedApr 2026 · 13 investors · Other Health CareRule 506(b)
▶$2.7MraisedApr 2026 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alexander HastingsDirector
- Bernie NavarroExecutive Officer
- Baruch LieberExecutive Officer, Director
- Ajay WakhlooExecutive Officer, Director
- John McEleneyDirector
- Offering amount
- $6.5M
- Amount sold
- $2.7M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.2MraisedJun 2024 · 46 investors · Other Health CareRule 506(b)
▶$8.2MraisedJun 2024 · 46 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ajay WakhlooExecutive Officer, Director
- Marc LitzenbergExecutive Officer, Director
- Baruch LieberExecutive Officer, Director
- Bernardo NavarroExecutive Officer
- Offering amount
- $8.4M
- Amount sold
- $8.2M
- Finders' fees
- $250K
- Placement agents
- Andrew Bazarian, Christopher Lear, Elliot Sax
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$345KraisedJul 2022 · 8 investors · Other Health CareRule 506(b)
▶$345KraisedJul 2022 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bernardo NavarroExecutive Officer
- Ajay WakhlooExecutive Officer, Director
- Baruch LieberExecutive Officer, Director
- Marc LitzenbergExecutive Officer, Director
- Offering amount
- $345K
- Amount sold
- $345K
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$287.1KraisedSep 2020 · 7 investors · Other Health CareRule 506(b)
▶$287.1KraisedSep 2020 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marc LitzenbergExecutive Officer, Director
- Baruch LieberExecutive Officer, Director
- Bernardo NavarroExecutive Officer
- Ajay WakhlooExecutive Officer, Director
- Offering amount
- $697.2K
- Amount sold
- $287.1K
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Prometheus Therapeutics raised?
- Prometheus Therapeutics has disclosed $11.6M raised across 4 rounds.
- Where is Prometheus Therapeutics headquartered?
- Prometheus Therapeutics is headquartered in Miramar, US.